Clinical Trials Logo

Clinical Trial Summary

Muscle inhibition prevents optimal contraction of the quadriceps muscle due to changes in the nervous system after knee joint injury. Current treatments for muscle inhibition at this time include knee joint cryotherapy and electric stimulation prior to exercise. These treatments, in addition to strengthening exercises, have shown improvements in the quality and strength of muscle contractions however, they have a short window of effectiveness. Electromyographic Biofeedback is proven to be useful in improving quadriceps strength but the mechanism of action remains somewhat unclear. Therefore, the purpose of this investigation is to compare the effectiveness of electromyographic biofeedback supplemented exercise when compared to traditional exercise on quadriceps muscle function in individuals with a history of knee injury and current evidence of quadriceps inhibition. We hypothesize that 14 days of electromyographic biofeedback supplemented exercise will lead to larger gains in quadriceps activation when compared to traditional exercise.

Thirty 18-40 year old participants with a history of knee injury and current evidence of quadriceps muscle inhibition will be enrolled in this single blind randomized controlled trial. Participants will provide written consent prior to all study procedures. Following enrollment, participants will be asked complete questionnaires related to knee related function, current levels of pain, and current activity level followed by completion of baseline measurements.

1. We will use the superimposed burst technique to quadriceps muscle activation.

2. We will measure the Hoffmann reflex response of the quadriceps with surface electromyography. We will measure this signal with surface electromyography electrodes that record the activity of the quadriceps muscle through the skin.

Participants in both groups will be instructed on a 14 day home exercise protocol on the day of enrollment. The protocol is comprised of 4 exercises focused on both non-weight bearing and weight bearing quadriceps strengthening. Compliance will be monitored via a daily exercise diary which will be collected at the end of the study protocol.

Quadriceps central activation ratio, active motor threshold and Hoffmann reflex will be reported descriptively. Pre-intervention and post 14 day intervention quadriceps central activation ratio and Hoffmann reflex will be compared between traditional exercise and Biofeedback supplemented exercise


Clinical Trial Description

Screening Subjects will be asked to complete a brief questionnaire about their lower extremity, which will be used to determine if they exhibit any of the exclusionary criteria (administered by the Study Coordinator). This will include past medical history, headache/ migraine history, and any drugs/medications they are currently taking (which might influence the excitability threshold Hoffman reflex (H-reflex) measurement or central activation ratio). Subjects will also undergo quadriceps central activation ratio testing to determine the level of quadriceps inhibition. Upon review of the questionnaire and quadriceps central activation ratio, the study coordinator will determine a subject's eligibility (based on the inclusion and exclusion criteria). We will also collect age, height and weight for all subjects. Participants that qualify will provide written at this time which will be documented by the investigator.

Quadriceps Central Activation Ratio We will use the superimposed burst technique to measure quadriceps muscle strength and to estimate quadriceps activation by calculating the central activation ratio. Subjects will be secured to a chair (Biodex multi-mode dynamometer) with their knees and hips bent to approximately 90 degrees. Subjects will perform a maximal, voluntary isometric knee extension contraction (MVIC) with continuous verbal encouragement from the tester. Once the MVIC reaches a plateau (representing subjects' maximal effort) an electrical stimulus will be manually triggered and delivered directly to the quadriceps through 2 stimulating electrodes which will be secured to the subjects' anterior thigh. The stimulus will cause the quadriceps to twitch resulting in a temporary increase in force production which we will measure. A ratio between the MVIC force and the highest force achieved due to the electrical stimulation will be calculated - this is called the central activation ratio. The electrical stimulus will be delivered manually with a square-wave stimulator in conjunction with a stimulus isolation unit) and will consist of a train of 10 consecutive, square wave pulses of 600 microsecond duration, at an intensity of 125 volts with a carrier frequency of 100 pulses per second. Subjects will have the option of experiencing some "practice" pulses at lower intensity in order to become acclimated to the stimulus and the practice maintaining maximum effort in anticipation of the stimulation.

Randomization Randomization will take place after enrollment and screening take place. The assessor will be blinded in this investigation. Therefore, the clinician responsible for educating patients regarding the exercise protocols will also be responsible for randomization. Randomization will take place on a 1:1 basis. Prior to starting the study, a binary random number generator will be used to generate the randomization scheme. These numbers will then by placed in sealed envelopes and label with individual subject numbers. The randomization envelopes will be stored in a locked drawer and will only be removed by the clinician responsible for randomization. The randomization envelope will then be stored in the participant's research folder.

Quadriceps Hoffmann Reflex We will record muscle reflex activity by delivering a short percutaneous (through the skin) electrical stimulation to femoral nerve located in the inguinal fold. We will measure the reflex response of the quadriceps with surface electromyography. This measure helps to describe the function of a muscle before and after our exercise protocol. Subjects will be positioned comfortably in a lying-down position on a treatment table. Stimuli will be delivered to the femoral nerve by increasing the intensity in small increments with a 10 second rest interval after each stimulus, until the maximum H-reflex amplitude is recorded (Hmax). Then we will increase the stimulus voltage until we obtain a maximum M-wave. The H-reflex represents the proportion of the quadriceps motor neuron pool that is available for voluntary contraction and the M-wave represents the total volume of the quadriceps motor neuron pool and will be used to normalize the H-reflex recordings as H:M ratio. This measurement will be performed bilaterally.

Exercise Intervention Participants in both groups will be instructed on a 14 day exercise (4 supervised session and 10 home sessions) protocol on the day of enrollment. The protocol is comprised of 4 exercises focused on both non-weight bearing and weight bearing quadriceps strengthening. All participants will be asked to complete 3 set of 10 repetitions of isometric quadriceps contractions with a 15 second hold time, supine straight leg raises, body weight squatting, and body weight lunges daily. Participants will be required to complete the single limb exercises on the previously injured limb only. A compliance log will be given to each participant and will be reviewed at each supervised exercise session and at the final study visit. Participants will be instructed to discontinue exercise and contact the principle investigator if they experience knee pain due to the intervention.

Participants in the electromyographic biofeedback supplemented exercise will also be instructed on correct setup and use of the electromyographic biofeedback unit. These instructions will focus on correct placement of the electromyography recording electrodes over quadriceps muscle as well as correct tuning of the feedback threshold for each exercise to maximize the benefit of the intervention. Electromyographic biofeedback will be used during all exercises throughout the course of the study for this group.

Follow-up Testing After 14±1 days of exercise intervention all baseline measures will be re-tested in the same manner as explained above. A supervised exercise session and compliance check will be completed 3±1, 7±1, and 10±1 days following enrollment into the study. No follow-up measurements will be taken at this point, however an exercise compliance log will be collected from all participants. ;


Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT02095223
Study type Interventional
Source University of Miami
Contact
Status Terminated
Phase N/A
Start date December 2013
Completion date August 2015

See also
  Status Clinical Trial Phase
Recruiting NCT04554212 - Blood Flow Restriction Training After Patellar INStability N/A
Completed NCT04815980 - Impact of Pilates on Running Mechanics N/A
Not yet recruiting NCT05484778 - Analysis of Balance and Functional Hop Tests Used for Return to Sports in Athletes With Lower Extremity Injuries by Dual Task Study N/A
Terminated NCT02909257 - Motor-Sparing Femoral Nerve Block Dose Phase 4
Completed NCT02540811 - Clinical Evaluation of dCELL® ACL Scaffold for Reconstruction of the Anterior Cruciate Ligament N/A
Recruiting NCT03755388 - Clinical Trial of an MRI Based Patient Specific Focal Knee Resurfacing Implant N/A
Recruiting NCT00174213 - Validity and Reliability in Measuring Iliotibial Tract by Using Ultrasound Phase 1
Completed NCT03202901 - Accute Effect of B-Turmactive Both on Mild and Moderate Knee Pain on Healthy Volunteers N/A
Completed NCT06206018 - Patient-Reported Outcome Measures in Lower Extremity Rehabilitation Program PROM_R: Impact on Health Care N/A
Completed NCT04543227 - Opioid Laws and Pediatric Use
Completed NCT06078072 - Biomaterials and Mesenchymal Stem/Stromal Cells in the Treatment of Knee Articular Surface Lesions
Completed NCT04956393 - The SOAR (Stop OsteoARthritis) Program Proof-of-Concept Study N/A
Recruiting NCT06451510 - Knee Osteoarthritis in the Region of Norrbotten
Completed NCT04118023 - 7T MRI to Evaluate Cartilage Defects in the Knee
Completed NCT03486405 - A Randomized Control Trial: Returning to Run After Injury N/A
Recruiting NCT03858231 - Opioids Versus Non-Opioids Postoperative After Knee Arthroscopic Surgery Phase 4
Recruiting NCT02918734 - Fixation of Patellar Tendon Grafts in Anterior Cruciate Ligament Reconstruction. Endobutton vs Metal Interference Screws N/A
Suspended NCT02270905 - Clinical Evaluation of dCELL® Meniscus for Partial Replacement of the Meniscus N/A
Completed NCT01227694 - Adult Stem Cell Therapy for Repairing Articular Cartilage in Gonarthrosis Phase 1/Phase 2
Completed NCT00991588 - Clinical Outcome of Posterior Cruciate Ligament (PCL) Posterolateral Reconstruction